James Woody

Chief Executive Officer at 180Life Sciences

Member's Links: 180Life Sciences

General Partner of Latterell Venture Partners Founded Avidia & Proteolix, both sold to Amgen Board member of ForteBio & ProteinSimple, both successfully acquired Past President & GM of Roche Bioscience (Syntex) Developed Remicade at Centocor while serving as CSO and SVP of R&D Prior Commanding ...more

Following: 35 Followers: 2

Education

School Name:	Duke University School of Medicine
Degree:	Residency
Fields of study:	Residency, Pediatrics Program

School Name:	Harvard University, Children's Hospita
Degree:	Residency
Fields of study:	Pediatrics Residency Program

School Name:	UCL
Degree:	PhD
Fields of study:	Doctor of Philosophy (PhD), Immunology

School Name:	Loma Linda University
Degree:	PhD
Time Period:	1964 / 1968
Fields of study:	Doctor of Medicine (MD) PhD

Work Experience

Title:	Chief Executive Officer
Company:	180Life Sciences (Nasdaq: ATNF)
Time Period:	August 2020 - Present (3 years 11 months)
Description:	http://180lifesciences.com Menlo Park, California, United States

Title:	General Partner
Company:	Latterell Venture Partners
Time Period:	2005 - Present (19 years 9 months)
Description:	Research and identify good scientific opportunities to support with venture funding. Assist in guiding management in drug or instrument development to meet critical needs.

Publications

Following (0)

Followers (0)

Stocks I follow

General Stats

Article Comments

Received:	0
Created:	0